from AIR LIQUIDE (EPA:AI)
Air Liquide signs with 20 hospitals to help them reduce their carbon footprint
PRESS RELEASE
Paris, January 20, 2025
Air Liquide signs with 20 hospitals to help them reduce their carbon footprint
Reflecting healthcare facilities' growing interest in reducing their carbon footprint, Air Liquide Healthcare's ECO ORIGIN™ offer is experiencing strong development. Less than a year after launching its solution for healthcare players, the company has already signed in 2024 contracts with 19 hospitals and clinics in six European countries (Belgium, France, Germany, Italy, Netherlands, Spain). Air Liquide Healthcare also announces its first contract in Brazil, with a renowned hospital in Sao Paulo, for the supply of certified low-carbon oxygen and nitrogen.
While the healthcare sector worldwide accounts for 4% of global CO2 emissions1, several European countries have adopted emission reduction targets that encourage healthcare systems to reduce their environmental impact.
With the ECO ORIGIN™ offer, launched in early 2024 for healthcare players, Air Liquide Healthcare offers certified low-carbon2 medical gases, liquid oxygen and liquid nitrogen,produced using electricity from 100% renewable energy sources to hospitals. Air Liquide Healthcare is also committed to reducing the share of emissions linked to transport, through the optimization of delivery routes and the introduction of alternative fuels. The ECO ORIGIN™ offer allows to reduce the carbon footprint of medical gas supplies by an average of more than 70% compared with a standard supply.
Diana Schillag, member of Air Liquide's Executive Committee in charge of Healthcare, Sustainable Development and Procurement, stated: "By ensuring traceability of the carbon footprint of medical gases - from production to delivery - our offer is increasingly appealing to hospital customers keen to reduce the environmental impact of their activities. It is fully in line with our ADVANCE strategic plan, combining growth dynamic and contribution to progress through innovation. As a responsible partner, Air Liquide Healthcare works alongside healthcare professionals to guarantee the supply of gases and simplify their management, while providing them with low-carbon solutions."
Air Liquide Healthcare
Air Liquide Healthcare is a world leader in medical gases, home healthcare services and specialty ingredients. Our 16,500 employees support 2 million chronic patients and provide medical gases and related services to 20,000 hospitals and new care facilities, as well as 140,000 healthcare professionals. Committed to working alongside professionals and health institutions, our patient-centered approach is based on the principles of Value-based Healthcare, which aims to improve the benefits experienced by patients, at the best cost to society, thus contributing to a more efficient and virtuous system.
CONTACTS Corporate Communications media@airliquide.com | Investor Relations IRTeam@airliquide.com
|
1 Healthcare’sclimatefootprint
2 Certified by an independent organization, in compliance with international ISO standards 14021/ 14067
Follow Air Liquide on LinkedIn
Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 60 countries with 66,300 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition—particularly with hydrogen—and takes action to progress in areas of healthcare, digital and high technologies.
Air Liquide’s revenue amounted to more than 27.5 billion euros in 2023. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.
Follow Air Liquide on LinkedIn